Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

09-19-2019 | Vildagliptin | Highlight | Article

Expert commentary: The VERIFY trial

Amrit Lamba discusses how the findings of VERIFY may influence how primary care practitioners will approach first-line treatment of people with type 2 diabetes (4:32).

Diagnosis and management of prediabetes: a consensus of GCC countries

Guidance in addressing the diagnosis and treatment of prediabetes, intended for healthcare professionals practicing in Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman.

Funding for this roadmap was provided by Merck Serono Middle East FZ-LLC

09-19-2019 | Heart failure | Video | Article

Expert commentary: DAPA-HF and DEFINE-HF trials

Lars Rydén discusses how the results of the DAPA-HF and DEFINE-HF trials will impact treatment decisions for patients with heart failure (6:38).

55th EASD Annual Meeting coverage

Including news and expert commentaries on the VERIFY trial, DEFINE-HF trial, and PRIORITY study

Latest from across the site

09-19-2019 | Continuous glucose monitoring | EASD 2019 | News

Majority of MDI users improve glycemic outcomes with CGM

Analysis of the GOLD study suggests that at least three-quarters of people with type 1 diabetes using multiple daily injections benefit from continuous glucose monitoring.

09-19-2019 | Type 2 diabetes | News

IL-1 inhibition may benefit for people with rheumatoid arthritis, type 2 diabetes

Treatment with the interleukin-1 inhibitor anakinra improves both glycemic and inflammatory endpoints among patients with rheumatoid arthritis and type 2 diabetes, suggest findings from the TRACK trial.

09-18-2019 | Pathophysiology | EASD 2019 | News

‘Strikingly different’ drivers of early type 2 diabetes onset in Asians, Europeans

The “classic” metabolic contributors to early-onset type 2 diabetes risk in European people explain little of the risk in Asian people, shows a comparison of Scottish and Asian Indian cohorts.

09-18-2019 | Pathogenesis | EASD 2019 | News

Type 2 diabetes genetic liability manifests in early lipid changes

Genetic liability to type 2 diabetes manifests in altered lipid profiles from as early as 8 years of age, say researchers.

09-17-2019 | Semaglutide | EASD 2019 | News

PIONEER data support oral semaglutide across a wide range of patients

Researchers at the 55th EASD Annual Meeting in Barcelona, Spain, have presented primary data and subanalyses from a number of the PIONEER trials investigating the efficacy of oral semaglutide in people with type 2 diabetes.

09-17-2019 | Glycemic control | EASD 2019 | News

Suboptimal glycemic control shown in adults with type 1 diabetes

Results of the SAGE study demonstrate suboptimal glycemic control among adults of all ages with type 1 diabetes across the globe.

ADVERTISEMENT

Flash glucose monitoring technology

Downloadable slide sets from key clinical trials in people with diabetes

Meet our Editorial Board

New Content Item Meet our Advisory Board

Latest from us on Twitter

Trending this week

Image Credits